A clinical trial of E0659 nasal gel spray on perennial allergic rhinitis

DOI

Bibliographic Information

Other Title
  • E0659点鼻ゲルの通年性アレルギー性鼻炎に対する臨床的検討
  • 用法検討試験

Abstract

To determine the optimal regimen for E0659 nasal gel spray in perennial allergic rhinitis, a multicenter single-blind study was carried out by administering E0659 15μgispray in both b.i.d. and t.i.d. regimens,<BR>1. The final global improvement rating was 52% for the b.i.d. group and 43% for the t.i.d. group, based on “good to excellent” responses. Therefore, the result between the b.i.d. and the t.i.d. regimens were considered to be clinically similar.<BR>2. The overall safety rating based on “no safety problems” was 97% for b.i.d. and 98% for the t.i.d. group, so no difference in the overall safety rating was observed between the b.i.d. and the t.i.d. regimens.<BR>3. The utility rating was 57% for the b.i.d. group and 48% for the t.i.d. group based on a finding of “useful to very useful”, so again the findings for the b.i.d. and t.i.d.regimens were found to be similar.<BR>Based on the above findings, the b.i.d. treatment regimen is therefore considered to be the optimal regimens for E0659 nasal spray.

Journal

Details 詳細情報について

  • CRID
    1390282680476222080
  • NII Article ID
    130004404232
  • DOI
    10.11334/jibi1954.42.2_184
  • ISSN
    04477227
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top